BACKGROUND Prostate carcinoma (PC) frequently metastasizes to bone, where it causes significant morbidity and mortality. Stromal elements in the primary and metastatic target organs are important mediators of tumor cell intravasation, chemoattraction, adhesion to target organ microvascular endothelium, extravasation, and growth at the metastatic site. METHODS The role of stromal factors in bone metastasis was determined with a cyclic DNA microarray comparison of a bone-derived cell PC cell line with a soft tissue-derived cell PC cell line and by evaluating the effects of selected stromal components on PC cell chemotaxis, cell adhesion to human bone marrow endothelium (HBME), and PC cell growth. RESULTS The authors demonstrate that PC c...
Abstract Metastatic prostate cancer is one of the leading causes of cancer-related death in men. The...
Advanced prostate cancer is frequently accompanied by the development of metastasis to bone. In the ...
The onset of metastases dramatically changes the prognosis of prostate cancer patients, determining ...
The majority of men with progressive prostate cancer develop metastases with the skeleton being the ...
Human prostate cancers (PCa) express great variability in their ability to metastasize to bone. The ...
protein, stromal-derived factor, matrix metalloproteinase The majority of men with progressive prost...
Advanced-stage prostate cancer (PCa) patients are often diagnosed with bone metastases. Bone metasta...
Neoplasms have a striking tendency to metastasize or "home" to bone. Hematopoietic cells also home t...
The interplay in prostate cancer bone metastases between the 'seed' (the prostate cancer cells) and ...
BACKGROUND Stromal cell-derived factor-1 (SDF-1 or CXCL12) and CXCR4 are key elements in the metast...
Prostate cancer represents the most commonly diagnosed malignancies in American men and is the secon...
Prostate cancer metastasis to the bone occurs at high frequency in patients with advanced disease, c...
Patients with advanced prostate cancer often develop bone metastases, leading to bone pain, skeletal...
BACKGROUND Despite the high incidence and serious consequences of skeletal metastasis in prostate c...
Bone is the most common site for metastasis in human prostate cancer patients. Skeletal metastases a...
Abstract Metastatic prostate cancer is one of the leading causes of cancer-related death in men. The...
Advanced prostate cancer is frequently accompanied by the development of metastasis to bone. In the ...
The onset of metastases dramatically changes the prognosis of prostate cancer patients, determining ...
The majority of men with progressive prostate cancer develop metastases with the skeleton being the ...
Human prostate cancers (PCa) express great variability in their ability to metastasize to bone. The ...
protein, stromal-derived factor, matrix metalloproteinase The majority of men with progressive prost...
Advanced-stage prostate cancer (PCa) patients are often diagnosed with bone metastases. Bone metasta...
Neoplasms have a striking tendency to metastasize or "home" to bone. Hematopoietic cells also home t...
The interplay in prostate cancer bone metastases between the 'seed' (the prostate cancer cells) and ...
BACKGROUND Stromal cell-derived factor-1 (SDF-1 or CXCL12) and CXCR4 are key elements in the metast...
Prostate cancer represents the most commonly diagnosed malignancies in American men and is the secon...
Prostate cancer metastasis to the bone occurs at high frequency in patients with advanced disease, c...
Patients with advanced prostate cancer often develop bone metastases, leading to bone pain, skeletal...
BACKGROUND Despite the high incidence and serious consequences of skeletal metastasis in prostate c...
Bone is the most common site for metastasis in human prostate cancer patients. Skeletal metastases a...
Abstract Metastatic prostate cancer is one of the leading causes of cancer-related death in men. The...
Advanced prostate cancer is frequently accompanied by the development of metastasis to bone. In the ...
The onset of metastases dramatically changes the prognosis of prostate cancer patients, determining ...